Form 4 for STLN Starling Oncology, Inc.
Accepted 2025-09-05 00:00:00 ET · period of report 2025-09-04 · accession 0001213900-25-084700 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-09-05 | 2025-09-04 | STLN | M33 Growth I GP LLC | Dir, 10% | S - Sale | $3.09 | -681.8K | 590.9K | -54% | -$2.11M |
| 2025-09-05 | 2025-09-04 | STLN | M33 Growth I GP LLC | Dir, 10% | S - Sale | $3.09 | -6.02M | 7.93M | -43% | -$18.60M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-04 | S | D | 681,832 | $3.09 | 590,892 | I | — | — | |
| 2 | Common | Common Stock | 2025-09-04 | S | D | 6,018,168 | $3.09 | 7,932,389 | D See Footnote | — | — | (F1) M33 Growth I GP LLC ("M33 LLC") is the general partner of M33 Growth I L.P. ("M33 LP") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein. (F2) These securities are held by TOI M, LLC. |